Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 5:13:955168.
doi: 10.3389/fimmu.2022.955168. eCollection 2022.

COVID-19 vaccinology landscape in Africa

Sara Baptista  1   2 , Sanushka Naidoo  1   3 , Sara Suliman  1   4   5 , Emmanuel Nepolo  1   6 , Bernard N Kanoi  7 , Jesse Gitaka  1   7 , Oyedemi Mbaebie Blessing  1   8 , Shymaa Enany  1   9
Affiliations

COVID-19 vaccinology landscape in Africa

Sara Baptista et al. Front Immunol. .

Abstract

More than two years after the start of COVID-19 pandemic, Africa still lags behind in terms vaccine distribution. This highlights the predicament of Africa in terms of vaccine development, deployment, and sustainability, not only for COVID-19, but for other major infectious diseases that plague the continent. This opinion discusses the challenges Africa faces in its race to vaccinate its people, and offers recommendations on the way forward. Specifically, to get out of the ongoing vaccine shortage trap, Africa needs to diversify investment not only to COVID-19 but also other diseases that burden the population. The continent needs to increase its capacity to acquire vaccines more equitably, improve access to technologies to enable local manufacture of vaccines, increase awareness on vaccines both in rural and urban areas to significantly reduce disease incidence of COVID-19 and as well as other prevalent diseases on the African continent such as HIV and TB. Such efforts will go a long way to reduce the disease burden in Africa.

Keywords: Africa; COVID - 19; improved access; local manufacture; vaccines; vaccinology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
In order to alter the current COVID-19 vaccinology landscape in Africa, multiple approaches such as increased investments by African governments to support vaccines research and development, improved access to technologies that boost local manufacturing, and public education on benefits of vaccines, among others, will be needed.
See this image and copyright information in PMC

References

    1. WHO . COVID-19 vaccination in the WHO African region. (2022), 7 June 2022. Cite du Djoue, Brazzaville: WHO Regional Office for Africa.
    1. Sallam M, Al-Sanafi M, Sallam M. A global map of COVID-19 vaccine acceptance rates per country: An updated concise narrative review. J Multidiscip Healthc (2022) 15:21–45. doi: 10.2147/JMDH.S347669 - DOI - PMC - PubMed
    1. Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG. Return on investment from childhood immunization in low- and middle-income countries, 2011-20. Health Aff (Millwood) (2016) 35(2):199–207. doi: 10.1377/hlthaff.2015.1086 - DOI - PubMed
    1. Bradley EH, Taylor LA, Cuellar CJ. Management matters: A leverage point for health systems strengthening in global health. Int J Health Policy Manag (2015) 4(7):411–5. doi: 10.15171/ijhpm.2015.101 - DOI - PMC - PubMed
    1. GAVI . The vaccine alliance progress report 2019. (2020). Geneva, Switzerland: Gavi.

Publication types